HOXC10 and esophageal squamous cell carcinoma: As exhibited in Fig. 2F and G, we have confirmed that ESCC patients with high HOXC10 level had significantly poorer overall survival (OS) (p = 0.0334) and disease-free-survival (DFS) outcomes (p = 0.0244).